XML 54 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Balances and Transactions
 12 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Balances and Transactions Related Party Balances and Transactions
McKesson Europe had investments in pharmacies located across Europe that were accounted for under the equity method. McKesson Europe maintained distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million are included in the Consolidated Statement of Operations for the year ended March 31, 2022. Predominately all of these pharmacies were divested from the Company in the fourth quarter of fiscal 2022 as part of the completed divestiture of the Company’s Austrian business, and in fiscal 2023 as part of the completed divestitures of the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, “Business Acquisitions and Divestitures,” for additional information on the Company’s European divestiture activities.
For the year ended March 31, 2022, the Company’s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million. During fiscal 2022, the Company’s investment in this investee was no longer accounted for using the equity method and subsequently not considered a related party.